Cambridge biotech Rubius Therapeutics considers R.I. for pharmaceutical manufacturing facility

RUBIUS THERAPEUTICS Inc., based in Cambridge, Mass., is proposing a $155 million pharmaceutical manufacturing facility in Rhode Island.
PROVIDENCE – A Cambridge, Mass.-based biotech company may build a $155 million pharmaceutical manufacturing facility in Rhode Island, and is seeking state incentives from the R.I. Commerce Corp. The project put forward by Rubius Therapeutics Inc. is on the agenda for a subcommittee of the Commerce RI executive board Monday afternoon. The location of the…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -